The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017

Figures & data

Figure 1 The trend of prevalence of TTIs in Iranian donated bloods from 2003 to 2017.

Note: The Y-axis scale is different in each graph.

Figure 2 The geographic distribution of the period prevalence (2003–2017) of TTIs in Iranian donated bloods (per 100,000 donations).

Figure 3 The interrupted time series analysis of HIV (A), HBV (B), HCV (C) in Iranian donated bloods.

Table 1 ITS Parameters in the Trend of TTIs in Iranian Donated Bloods

HIV	Coefficient	Value	Standard Error	P
	Intercept	6.3	0.4	< 0.001
	Pre-intervention trend	−0.4	0.1	< 0.001
	Change in intercept immediately after intervention	0.52	0.5	0.3
	Change in the post-intervention trend	0.25	0.1	0.02
HBV	Coefficient	Value	Standard Error	P
	Intercept	895	7.4	< 0.001
	Pre-intervention trend	−87.2	1.7	< 0.001
	Change in intercept immediately after intervention	−28.3	9.2	0.01
	Change in the post-intervention trend	61.4	1.9	< 0.001
HCV	Coefficient	Value	Standard Error	P
	Intercept	173.1	2.8	< 0.001
	Pre-intervention trend	−10.5	0.6	< 0.001
	Change in intercept immediately after intervention	−25.5	3.4	< 0.001
	Change in the post-intervention trend	4.5	0.7	< 0.001